Moderna MRNA Europe — Total Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Moderna’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Moderna's europe — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Moderna's europe — total revenue?
- Moderna (MRNA) reported europe — total revenue of $13.25M in Q4 2025.
- How has Moderna's europe — total revenue changed year-over-year?
- Moderna's europe — total revenue decreased by 91.1% year-over-year, from $149.5M to $13.25M.
- What is the long-term trend for Moderna's europe — total revenue?
- Over 4 years (2021 to 2025), Moderna's europe — total revenue has grown at a -70.3% compound annual growth rate (CAGR), from $6.85B to $53M.
- What does europe — total revenue mean?
- This metric represents the total gross revenue generated from the sale of products and services within the European geographic segment. It captures the market demand and commercial success of the company's portfolio in this specific region. Tracking this helps investors understand the geographic concentration of sales and the company's ability to penetrate European healthcare markets.